Circulating miR-378 is increase in blood serum of renal cell carcinoma patients
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14740%2F13%3A00065635" target="_blank" >RIV/00216224:14740/13:00065635 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Circulating miR-378 is increase in blood serum of renal cell carcinoma patients
Original language description
Renal cell carcinoma is the most common neoplasm of adult kidney, having the highest mortality rate at over 40%. Renal tumors are commonly asymptomatic in early stages and although surgical resection remains the best therapy, after the curative nephrectomy 20-40% of patients will develop recurrence. Our aim was to identify serum biomarkers, which could be used for diagnosis or early detection of recurrence in renal cell carcinoma patients.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů